| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2503-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7275 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20 |
| filingDate |
2022-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3770c9bbe62f6b8224e8a3025326cee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_635e2d657dc2a949f2599786870ad104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70029751fcfe1374069fb141fa809156 |
| publicationDate |
2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022181028-A1 |
| titleOfInvention |
Algorithm for the identification and phenotyping of nonalcoholic fatty liver disease patients |
| abstract |
System and methods for diagnosing nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) in patients are disclosed. The system can comprise one or more processors and one or more computer-readable non-transitory storage media coupled to the one or more of processors including instructions operable when executed by one or more of the processor. The system can be configured to select at least one patient with a risk indicator using an electronic health record (EHR) database, determine that the at least one patient fails to meet exclusion criteria, and display the at least one patient in response to the determination. The risk indicator can be associated with NAFLD and/or NASH. Methods for diagnosing NAFLD/NASH in patients are disclosed are also provided. |
| priorityDate |
2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |